Full Text of SB1715 101st General Assembly
SB1715 101ST GENERAL ASSEMBLY |
| | 101ST GENERAL ASSEMBLY
State of Illinois
2019 and 2020 SB1715 Introduced 2/15/2019, by Sen. Michael E. Hastings SYNOPSIS AS INTRODUCED: |
| |
Amends the Pharmacy Practice Act. Provides that the "practice of pharmacy" includes the administration of injections of long-term antipsychotic medications pursuant to a valid prescription by a physician licensed to practice medicine in all its branches, upon completion of appropriate training, including how to address contraindications and adverse reactions set forth by rule, with notification to the patient's physician and appropriate record retention, or pursuant to hospital pharmacy and therapeutics committee policies and procedures.
|
| |
| | A BILL FOR |
|
| | | SB1715 | | LRB101 08622 JRG 53702 b |
|
| 1 | | AN ACT concerning regulation.
| 2 | | Be it enacted by the People of the State of Illinois,
| 3 | | represented in the General Assembly:
| 4 | | Section 5. The Pharmacy Practice Act is amended by changing | 5 | | Section 3 as follows:
| 6 | | (225 ILCS 85/3)
| 7 | | (Section scheduled to be repealed on January 1, 2020)
| 8 | | Sec. 3. Definitions. For the purpose of this Act, except | 9 | | where otherwise
limited therein:
| 10 | | (a) "Pharmacy" or "drugstore" means and includes every | 11 | | store, shop,
pharmacy department, or other place where | 12 | | pharmacist
care is
provided
by a pharmacist (1) where drugs, | 13 | | medicines, or poisons are
dispensed, sold or
offered for sale | 14 | | at retail, or displayed for sale at retail; or
(2)
where
| 15 | | prescriptions of physicians, dentists, advanced practice | 16 | | registered nurses, physician assistants, veterinarians, | 17 | | podiatric physicians, or
optometrists, within the limits of | 18 | | their
licenses, are
compounded, filled, or dispensed; or (3) | 19 | | which has upon it or
displayed within
it, or affixed to or used | 20 | | in connection with it, a sign bearing the word or
words | 21 | | "Pharmacist", "Druggist", "Pharmacy", "Pharmaceutical
Care", | 22 | | "Apothecary", "Drugstore",
"Medicine Store", "Prescriptions", | 23 | | "Drugs", "Dispensary", "Medicines", or any word
or words of |
| | | SB1715 | - 2 - | LRB101 08622 JRG 53702 b |
|
| 1 | | similar or like import, either in the English language
or any | 2 | | other language; or (4) where the characteristic prescription
| 3 | | sign (Rx) or similar design is exhibited; or (5) any store, or
| 4 | | shop,
or other place with respect to which any of the above | 5 | | words, objects,
signs or designs are used in any advertisement.
| 6 | | (b) "Drugs" means and includes (1) articles recognized
in | 7 | | the official United States Pharmacopoeia/National Formulary | 8 | | (USP/NF),
or any supplement thereto and being intended for and | 9 | | having for their
main use the diagnosis, cure, mitigation, | 10 | | treatment or prevention of
disease in man or other animals, as | 11 | | approved by the United States Food and
Drug Administration, but | 12 | | does not include devices or their components, parts,
or | 13 | | accessories; and (2) all other articles intended
for and having | 14 | | for their main use the diagnosis, cure, mitigation,
treatment | 15 | | or prevention of disease in man or other animals, as approved
| 16 | | by the United States Food and Drug Administration, but does not | 17 | | include
devices or their components, parts, or accessories; and | 18 | | (3) articles
(other than food) having for their main use and | 19 | | intended
to affect the structure or any function of the body of | 20 | | man or other
animals; and (4) articles having for their main | 21 | | use and intended
for use as a component or any articles | 22 | | specified in clause (1), (2)
or (3); but does not include | 23 | | devices or their components, parts or
accessories.
| 24 | | (c) "Medicines" means and includes all drugs intended for
| 25 | | human or veterinary use approved by the United States Food and | 26 | | Drug
Administration.
|
| | | SB1715 | - 3 - | LRB101 08622 JRG 53702 b |
|
| 1 | | (d) "Practice of pharmacy" means: | 2 | | (1) the interpretation and the provision of assistance | 3 | | in the monitoring, evaluation, and implementation of | 4 | | prescription drug orders; | 5 | | (2) the dispensing of prescription drug orders; | 6 | | (3) participation in drug and device selection; | 7 | | (4) drug administration limited to the administration | 8 | | of oral, topical, injectable, and inhalation as follows: | 9 | | (A) in the context of patient education on the | 10 | | proper use or delivery of medications; | 11 | | (B) vaccination of patients 14 years of age and | 12 | | older pursuant to a valid prescription or standing | 13 | | order, by a physician licensed to practice medicine in | 14 | | all its branches, upon completion of appropriate | 15 | | training, including how to address contraindications | 16 | | and adverse reactions set forth by rule, with | 17 | | notification to the patient's physician and | 18 | | appropriate record retention, or pursuant to hospital | 19 | | pharmacy and therapeutics committee policies and | 20 | | procedures; and | 21 | | (C) administration of injections of | 22 | | alpha-hydroxyprogesterone caproate, pursuant to a | 23 | | valid prescription, by a physician licensed to | 24 | | practice medicine in all its branches, upon completion | 25 | | of appropriate training, including how to address | 26 | | contraindications and adverse reactions set forth by |
| | | SB1715 | - 4 - | LRB101 08622 JRG 53702 b |
|
| 1 | | rule, with notification to the patient's physician and | 2 | | appropriate record retention, or pursuant to hospital | 3 | | pharmacy and therapeutics committee policies and | 4 | | procedures; and | 5 | | (D) administration of injections of long-term | 6 | | antipsychotic medications pursuant to a valid | 7 | | prescription by a physician licensed to practice | 8 | | medicine in all its branches, upon completion of | 9 | | appropriate training, including how to address | 10 | | contraindications and adverse reactions set forth by | 11 | | rule, with notification to the patient's physician and | 12 | | appropriate record retention, or pursuant to hospital | 13 | | pharmacy and therapeutics committee policies and | 14 | | procedures. | 15 | | (5) vaccination of patients ages 10 through 13 limited | 16 | | to the Influenza (inactivated influenza vaccine and live | 17 | | attenuated influenza intranasal vaccine) and Tdap (defined | 18 | | as tetanus, diphtheria, acellular pertussis) vaccines, | 19 | | pursuant to a valid prescription or standing order, by a | 20 | | physician licensed to practice medicine in all its | 21 | | branches, upon completion of appropriate training, | 22 | | including how to address contraindications and adverse | 23 | | reactions set forth by rule, with notification to the | 24 | | patient's physician and appropriate record retention, or | 25 | | pursuant to hospital pharmacy and therapeutics committee | 26 | | policies and procedures; |
| | | SB1715 | - 5 - | LRB101 08622 JRG 53702 b |
|
| 1 | | (6) drug regimen review; | 2 | | (7) drug or drug-related research; | 3 | | (8) the provision of patient counseling; | 4 | | (9) the practice of telepharmacy; | 5 | | (10) the provision of those acts or services necessary | 6 | | to provide pharmacist care; | 7 | | (11) medication therapy management; and | 8 | | (12) the responsibility for compounding and labeling | 9 | | of drugs and devices (except labeling by a manufacturer, | 10 | | repackager, or distributor of non-prescription drugs and | 11 | | commercially packaged legend drugs and devices), proper | 12 | | and safe storage of drugs and devices, and maintenance of | 13 | | required records. | 14 | | A pharmacist who performs any of the acts defined as the | 15 | | practice of pharmacy in this State must be actively licensed as | 16 | | a pharmacist under this Act.
| 17 | | (e) "Prescription" means and includes any written, oral, | 18 | | facsimile, or
electronically transmitted order for drugs
or | 19 | | medical devices, issued by a physician licensed to practice | 20 | | medicine in
all its branches, dentist, veterinarian, podiatric | 21 | | physician, or
optometrist, within the
limits of his or her | 22 | | license, by a physician assistant in accordance with
subsection | 23 | | (f) of Section 4, or by an advanced practice registered nurse | 24 | | in
accordance with subsection (g) of Section 4, containing the
| 25 | | following: (1) name
of the patient; (2) date when prescription | 26 | | was issued; (3) name
and strength of drug or description of the |
| | | SB1715 | - 6 - | LRB101 08622 JRG 53702 b |
|
| 1 | | medical device prescribed;
and (4) quantity; (5) directions for | 2 | | use; (6) prescriber's name,
address,
and signature; and (7) DEA | 3 | | registration number where required, for controlled
substances.
| 4 | | The prescription may, but is not required to, list the illness, | 5 | | disease, or condition for which the drug or device is being | 6 | | prescribed. DEA registration numbers shall not be required on | 7 | | inpatient drug orders. A prescription for medication other than | 8 | | controlled substances shall be valid for up to 15 months from | 9 | | the date issued for the purpose of refills, unless the | 10 | | prescription states otherwise.
| 11 | | (f) "Person" means and includes a natural person, | 12 | | partnership,
association, corporation, government entity, or | 13 | | any other legal
entity.
| 14 | | (g) "Department" means the Department of Financial and
| 15 | | Professional Regulation.
| 16 | | (h) "Board of Pharmacy" or "Board" means the State Board
of | 17 | | Pharmacy of the Department of Financial and Professional | 18 | | Regulation.
| 19 | | (i) "Secretary"
means the Secretary
of Financial and | 20 | | Professional Regulation.
| 21 | | (j) "Drug product selection" means the interchange for a
| 22 | | prescribed pharmaceutical product in accordance with Section | 23 | | 25 of
this Act and Section 3.14 of the Illinois Food, Drug and | 24 | | Cosmetic Act.
| 25 | | (k) "Inpatient drug order" means an order issued by an | 26 | | authorized
prescriber for a resident or patient of a facility |
| | | SB1715 | - 7 - | LRB101 08622 JRG 53702 b |
|
| 1 | | licensed under the
Nursing Home Care Act, the ID/DD Community | 2 | | Care Act, the MC/DD Act, the Specialized Mental Health | 3 | | Rehabilitation Act of 2013, the Hospital Licensing Act, or the | 4 | | University of Illinois Hospital Act, or a facility which is | 5 | | operated by the Department of Human
Services (as successor to | 6 | | the Department of Mental Health
and Developmental | 7 | | Disabilities) or the Department of Corrections.
| 8 | | (k-5) "Pharmacist" means an individual health care | 9 | | professional and
provider currently licensed by this State to | 10 | | engage in the practice of
pharmacy.
| 11 | | (l) "Pharmacist in charge" means the licensed pharmacist | 12 | | whose name appears
on a pharmacy license and who is responsible | 13 | | for all aspects of the
operation related to the practice of | 14 | | pharmacy.
| 15 | | (m) "Dispense" or "dispensing" means the interpretation, | 16 | | evaluation, and implementation of a prescription drug order, | 17 | | including the preparation and delivery of a drug or device to a | 18 | | patient or patient's agent in a suitable container | 19 | | appropriately labeled for subsequent administration to or use | 20 | | by a patient in accordance with applicable State and federal | 21 | | laws and regulations.
"Dispense" or "dispensing" does not mean | 22 | | the physical delivery to a patient or a
patient's | 23 | | representative in a home or institution by a designee of a | 24 | | pharmacist
or by common carrier. "Dispense" or "dispensing" | 25 | | also does not mean the physical delivery
of a drug or medical | 26 | | device to a patient or patient's representative by a
|
| | | SB1715 | - 8 - | LRB101 08622 JRG 53702 b |
|
| 1 | | pharmacist's designee within a pharmacy or drugstore while the | 2 | | pharmacist is
on duty and the pharmacy is open.
| 3 | | (n) "Nonresident pharmacy"
means a pharmacy that is located | 4 | | in a state, commonwealth, or territory
of the United States, | 5 | | other than Illinois, that delivers, dispenses, or
distributes, | 6 | | through the United States Postal Service, commercially | 7 | | acceptable parcel delivery service, or other common
carrier, to | 8 | | Illinois residents, any substance which requires a | 9 | | prescription.
| 10 | | (o) "Compounding" means the preparation and mixing of | 11 | | components, excluding flavorings, (1) as the result of a | 12 | | prescriber's prescription drug order or initiative based on the | 13 | | prescriber-patient-pharmacist relationship in the course of | 14 | | professional practice or (2) for the purpose of, or incident | 15 | | to, research, teaching, or chemical analysis and not for sale | 16 | | or dispensing. "Compounding" includes the preparation of drugs | 17 | | or devices in anticipation of receiving prescription drug | 18 | | orders based on routine, regularly observed dispensing | 19 | | patterns. Commercially available products may be compounded | 20 | | for dispensing to individual patients only if all of the | 21 | | following conditions are met: (i) the commercial product is not | 22 | | reasonably available from normal distribution channels in a | 23 | | timely manner to meet the patient's needs and (ii) the | 24 | | prescribing practitioner has requested that the drug be | 25 | | compounded.
| 26 | | (p) (Blank).
|
| | | SB1715 | - 9 - | LRB101 08622 JRG 53702 b |
|
| 1 | | (q) (Blank).
| 2 | | (r) "Patient counseling" means the communication between a | 3 | | pharmacist or a student pharmacist under the supervision of a | 4 | | pharmacist and a patient or the patient's representative about | 5 | | the patient's medication or device for the purpose of | 6 | | optimizing proper use of prescription medications or devices. | 7 | | "Patient counseling" may include without limitation (1) | 8 | | obtaining a medication history; (2) acquiring a patient's | 9 | | allergies and health conditions; (3) facilitation of the | 10 | | patient's understanding of the intended use of the medication; | 11 | | (4) proper directions for use; (5) significant potential | 12 | | adverse events; (6) potential food-drug interactions; and (7) | 13 | | the need to be compliant with the medication therapy. A | 14 | | pharmacy technician may only participate in the following | 15 | | aspects of patient counseling under the supervision of a | 16 | | pharmacist: (1) obtaining medication history; (2) providing | 17 | | the offer for counseling by a pharmacist or student pharmacist; | 18 | | and (3) acquiring a patient's allergies and health conditions.
| 19 | | (s) "Patient profiles" or "patient drug therapy record" | 20 | | means the
obtaining, recording, and maintenance of patient | 21 | | prescription
information, including prescriptions for | 22 | | controlled substances, and
personal information.
| 23 | | (t) (Blank).
| 24 | | (u) "Medical device" or "device" means an instrument, | 25 | | apparatus, implement, machine,
contrivance, implant, in vitro | 26 | | reagent, or other similar or related article,
including any |
| | | SB1715 | - 10 - | LRB101 08622 JRG 53702 b |
|
| 1 | | component part or accessory, required under federal law to
bear | 2 | | the label "Caution: Federal law requires dispensing by or on | 3 | | the order
of a physician". A seller of goods and services who, | 4 | | only for the purpose of
retail sales, compounds, sells, rents, | 5 | | or leases medical devices shall not,
by reasons thereof, be | 6 | | required to be a licensed pharmacy.
| 7 | | (v) "Unique identifier" means an electronic signature, | 8 | | handwritten
signature or initials, thumb print, or other | 9 | | acceptable biometric
or electronic identification process as | 10 | | approved by the Department.
| 11 | | (w) "Current usual and customary retail price" means the | 12 | | price that a pharmacy charges to a non-third-party payor.
| 13 | | (x) "Automated pharmacy system" means a mechanical system | 14 | | located within the confines of the pharmacy or remote location | 15 | | that performs operations or activities, other than compounding | 16 | | or administration, relative to storage, packaging, dispensing, | 17 | | or distribution of medication, and which collects, controls, | 18 | | and maintains all transaction information. | 19 | | (y) "Drug regimen review" means and includes the evaluation | 20 | | of prescription drug orders and patient records for (1)
known | 21 | | allergies; (2) drug or potential therapy contraindications;
| 22 | | (3) reasonable dose, duration of use, and route of | 23 | | administration, taking into consideration factors such as age, | 24 | | gender, and contraindications; (4) reasonable directions for | 25 | | use; (5) potential or actual adverse drug reactions; (6) | 26 | | drug-drug interactions; (7) drug-food interactions; (8) |
| | | SB1715 | - 11 - | LRB101 08622 JRG 53702 b |
|
| 1 | | drug-disease contraindications; (9) therapeutic duplication; | 2 | | (10) patient laboratory values when authorized and available; | 3 | | (11) proper utilization (including over or under utilization) | 4 | | and optimum therapeutic outcomes; and (12) abuse and misuse.
| 5 | | (z) "Electronically transmitted prescription" means a | 6 | | prescription that is created, recorded, or stored by electronic | 7 | | means; issued and validated with an electronic signature; and | 8 | | transmitted by electronic means directly from the prescriber to | 9 | | a pharmacy. An electronic prescription is not an image of a | 10 | | physical prescription that is transferred by electronic means | 11 | | from computer to computer, facsimile to facsimile, or facsimile | 12 | | to computer.
| 13 | | (aa) "Medication therapy management services" means a | 14 | | distinct service or group of services offered by licensed | 15 | | pharmacists, physicians licensed to practice medicine in all | 16 | | its branches, advanced practice registered nurses authorized | 17 | | in a written agreement with a physician licensed to practice | 18 | | medicine in all its branches, or physician assistants | 19 | | authorized in guidelines by a supervising physician that | 20 | | optimize therapeutic outcomes for individual patients through | 21 | | improved medication use. In a retail or other non-hospital | 22 | | pharmacy, medication therapy management services shall consist | 23 | | of the evaluation of prescription drug orders and patient | 24 | | medication records to resolve conflicts with the following: | 25 | | (1) known allergies; | 26 | | (2) drug or potential therapy contraindications; |
| | | SB1715 | - 12 - | LRB101 08622 JRG 53702 b |
|
| 1 | | (3) reasonable dose, duration of use, and route of | 2 | | administration, taking into consideration factors such as | 3 | | age, gender, and contraindications; | 4 | | (4) reasonable directions for use; | 5 | | (5) potential or actual adverse drug reactions; | 6 | | (6) drug-drug interactions; | 7 | | (7) drug-food interactions; | 8 | | (8) drug-disease contraindications; | 9 | | (9) identification of therapeutic duplication; | 10 | | (10) patient laboratory values when authorized and | 11 | | available; | 12 | | (11) proper utilization (including over or under | 13 | | utilization) and optimum therapeutic outcomes; and | 14 | | (12) drug abuse and misuse. | 15 | | "Medication therapy management services" includes the | 16 | | following: | 17 | | (1) documenting the services delivered and | 18 | | communicating the information provided to patients' | 19 | | prescribers within an appropriate time frame, not to exceed | 20 | | 48 hours; | 21 | | (2) providing patient counseling designed to enhance a | 22 | | patient's understanding and the appropriate use of his or | 23 | | her medications; and | 24 | | (3) providing information, support services, and | 25 | | resources designed to enhance a patient's adherence with | 26 | | his or her prescribed therapeutic regimens. |
| | | SB1715 | - 13 - | LRB101 08622 JRG 53702 b |
|
| 1 | | "Medication therapy management services" may also include | 2 | | patient care functions authorized by a physician licensed to | 3 | | practice medicine in all its branches for his or her identified | 4 | | patient or groups of patients under specified conditions or | 5 | | limitations in a standing order from the physician. | 6 | | "Medication therapy management services" in a licensed | 7 | | hospital may also include the following: | 8 | | (1) reviewing assessments of the patient's health | 9 | | status; and | 10 | | (2) following protocols of a hospital pharmacy and | 11 | | therapeutics committee with respect to the fulfillment of | 12 | | medication orders.
| 13 | | (bb) "Pharmacist care" means the provision by a pharmacist | 14 | | of medication therapy management services, with or without the | 15 | | dispensing of drugs or devices, intended to achieve outcomes | 16 | | that improve patient health, quality of life, and comfort and | 17 | | enhance patient safety.
| 18 | | (cc) "Protected health information" means individually | 19 | | identifiable health information that, except as otherwise | 20 | | provided, is:
| 21 | | (1) transmitted by electronic media; | 22 | | (2) maintained in any medium set forth in the | 23 | | definition of "electronic media" in the federal Health | 24 | | Insurance Portability and Accountability Act; or | 25 | | (3) transmitted or maintained in any other form or | 26 | | medium. |
| | | SB1715 | - 14 - | LRB101 08622 JRG 53702 b |
|
| 1 | | "Protected health information" does not include | 2 | | individually identifiable health information found in: | 3 | | (1) education records covered by the federal Family | 4 | | Educational Right and Privacy Act; or | 5 | | (2) employment records held by a licensee in its role | 6 | | as an employer. | 7 | | (dd) "Standing order" means a specific order for a patient | 8 | | or group of patients issued by a physician licensed to practice | 9 | | medicine in all its branches in Illinois. | 10 | | (ee) "Address of record" means the designated address | 11 | | recorded by the Department in the applicant's application file | 12 | | or licensee's license file maintained by the Department's | 13 | | licensure maintenance unit. | 14 | | (ff) "Home pharmacy" means the location of a pharmacy's | 15 | | primary operations.
| 16 | | (gg) "Email address of record" means the designated email | 17 | | address recorded by the Department in the applicant's | 18 | | application file or the licensee's license file, as maintained | 19 | | by the Department's licensure maintenance unit. | 20 | | (Source: P.A. 99-180, eff. 7-29-15; 100-208, eff. 1-1-18; | 21 | | 100-497, eff. 9-8-17; 100-513, eff. 1-1-18; 100-804, eff. | 22 | | 1-1-19; 100-863, eff. 8-14-18 .)
|
|